This is a preview of subscription content, log in via an institution to check access.
REFERENCES
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, (4th ed.). Washington, DC: Author.
DelGiuidce-Asch, G. & Hollander, E. (1997). Altered immune function in autism. CNS Spectrums: International Journal of Neuropsychiatric Medicine, 2, 61–68.
Dwyer, J. M. (1992). Manipulating the immune system with immunoglobulin. New England Journal of Medicine, 326, 4104–4109.
Edan, G. & Landgraf, F. (1994). Experience with intravenous immunoglobulin in myasthenia gravis: a review. Journal of Neurology, Neurosurgery, and Psychiatry, 57, S55–56.
Freeman, B. J. Ritvo, E. R., Yokota, A., & Ritvo A. (1986). A scale for rating symptoms of patients with the syndrome of autism in real life settings. Journal of the American Academy of Child Psychiatry, 25, 130–136.
Goodman, W., Price, L., Ramussen, S., & Mazure, C. (1989a). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Part 1. Development, use, and reliability. Archives of General Psychiatry, 46, 1006–1011.
Goodman, W., Price, L., Ramussen, S., & Mazure, C. (1989b). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Part 2. Validity. Archives of General Psychiatry, 46, 1012–1016.
Gupta, S., Aggarwal, S., & Heads, C. (1996). Brief report: Dysregulated immune system in children with autism; beneficial effects of intravenous immune globulin on autistic characteristics. Journal of J Autism and Developmental Disorders, 26, 439–452.
Guy, W. (1976). E.C.D.E.U. Assessment manual for psychopharmacology (DHEW Publication, pp. 76–338). Washington DC: U.S.Government Printing Office.
Kanner, L. (1943). Autistic disturbances of affective contact. Nervous Child, 2, 217–250.
Le Couteur, A., Rutter, M., Lord, C., & Rios, P. (1989). Autism Diagnostic Interview: A semistructured interview for parents and caregivers of autistic persons. Journal of Autism and Developmental Disorders, 19, 363–387.
Plioplys, A. V., Greaves, A., & Yoshida W. (1989). Anti-CNS anti-bodies in childhood neurologic diseases. Neuropaediatrics, 20, 92–102.
Rapoport, J., Elkins, R., Mikkelsen, E. (1980). Clinical controlled trial of clomipramine in adolescents with obsessive compulsive disorder. Psychopharmacology Bulletin, 16(3), 61–63.
Singh, V. K., Fudenberg, H. H., Emerson, D., & Coleman, M. (1988). Immunodiagnosis and immunotheraphy in autistic children. Annals of the New York Academy of Science, 540, 602–604.
Singh, V. K., Warren, R. P., Odell, J. D., & P. Cole (1991). Changes of soluble IL-2, IL-2R, T8 antigen and IL-1 in the serum of autistic children. Clinical Immunology and Immunopathology, 61, 448–455.
Singh, V. K., Warren, R. P., Odell J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior and Immunology, 7, 97–103.
Todd, R. D., & Ciaranello, R. D. (1985). Demonstration of inter-and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proceedings of the National Academy of Science U.S., 82, 612–616.
Vajsar, J., Sloane, A., Wood, E., & Murphy, E. G. (1994). Plasmaphaersis versus Intravenous immunoglobulin in childhood Guillan-Barre syndrome. Archives of Pediatric and Adolescent Medicine, 148, 1210–1212.
van Engelen, B. G., Renier, W. O., Weemas, C. M., Gabreels, F. J., & Meinardi, H. (1994). Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Research, 19, 181–190.
Van Schaik, I. L., Vermeulen, M., van Doorn, P. A., & Brand A. (1994). Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIG). Journal of Neuroimmunology, 54, 109–115.
Warren, R. P., Foster, A., Margaretten, N. C., & Pace, N. C. (1986). Immune abnormalities in patients with autism. Journal of Autism and Developmental Disorders, 16, 189–197.
Warren, R. P., Foster, A., & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333–335.
Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., & White, E. (1991). Increased frequency of the null allele at the complements C4B locus in autism. Clinical and Experimental Immunology, 83, 438–440.
Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., DeWitt, C. W., & McCullough, M. (1992). Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunology, 36, 203–207.
Warren, R. P., Yonk, L. J., Burger, R. A., et al. (1990). Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest, 19, 245–251.
Yonk, L. J., Warren, R. P., Burger, R. A., et al. (1990). CD4 and helper T cell depression in autism. Immunology Letters, 25, 341–346.
Zimmerman, A., Frye, V. H., & Potter, N. T. (1993). Immunological aspects of autism. International Journal of Pediatrics, 8, 199–204.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DelGiudice-Asch, G., Simon, L., Schmeidler, J. et al. Brief Report: A Pilot Open Clinical Trial of Intravenous Immunoglobulin in Childhood Autism. J Autism Dev Disord 29, 157–160 (1999). https://doi.org/10.1023/A:1023096728131
Issue Date:
DOI: https://doi.org/10.1023/A:1023096728131